Home
Takara Bio Inc

Takara Bio Inc Market Share Analysis for November 2025

Get answers to your qPCR questions

Health > Biotechnology and Pharmaceuticals

Domaintakara-bio.co.jp

Year Founded1925

Employees201 - 500

Annual Revenue$25M - $50M

Takara Bio Inc

Takara Bio Inc (including company regionals)

takara-bio.co.jp

See more website traffic and engagement information

Takara Bio Inc Revenue up to November 2025 is 25M - 50M

revenue generated by Takara Bio Inc top domains

Takara Bio Inc top domains revenue over 3 years

Revenue for Takara Bio Inc top domains

takara-bio.co.jp25M - 50M

See more with Sales Intelligence

Total visits to Takara Bio Inc's top domains

Understand Takara Bio Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

takara-bio.co.jp164.8K

See more with Sales Intelligence

Avg. visit duration in Takara Bio Inc's top domains

Analyze Takara Bio Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

takara-bio.co.jp00:03:43

See more with Sales Intelligence

Avg. pageviews on Takara Bio Inc's top domains

See how Takara Bio Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

takara-bio.co.jp3.10

See more with Sales Intelligence

Takara Bio Inc top competitors by domain

Top similar sites in November 2025, ranked by their affinity

cosmobio.co.jpCompany NameCosmo Bio Co.Employees51 - 200HQJapan, TouyouAnnual revenue$75M - $100MTotal visits173.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Takara Bio Inc

These are the website technologies, by industry, used by Takara Bio Inc top domains

Advertising (4)

DoubleClick

Marketing (3)

Google Marketing Platform

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

10

See all

News & Signals from Takara Bio Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTakara Bio Inc. partnered with Otsuka on Apr 1st '18.In April 2018, Takara Bio entered into an agreement with Otsuka for co-development/exclusive sales of TBI-1301 in Japan and has since been engaged in co-development.

NewsTakara Bio Inc. is developing vaccines for the coronavirus.As nations scramble to develop vaccines for the coronavirus, Takara Bio is at the forefront of Japan's efforts, tapping its four decades of gene-editing experience to help develop a DNA-based approach that has never been used in humans before.